Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases

BACKGROUND: To investigate the significance of metastatic sites and their numbers to the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 232 patients who received ICI monotherapy or ICI-based combination therapy were r...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Qiao, Meng, Zhou, Fei, Hou, Likun, Li, Xuefei, Zhao, Chao, Jiang, Tao, Gao, Guanghui, Su, Chunxia, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859789/
https://ncbi.nlm.nih.gov/pubmed/33553327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1471
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items